December 31st, 2021 by WCBC Radio
The Maryland Department of Health (MDH) today announced that it is working with congregate care facilities, local health clinics, physicians, and pharmacies statewide to distribute the newly authorized antiviral medicines: Paxlovid and Molnupiravir.
These prescription pill regimens are the first oral antiviral treatments given Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for adults who test positive for COVID-19 and who have at least one risk factor for serious disease from COVID.
Both Paxlovid and Molnupiravir are prescribed in a five-day pill regimen. These two medications join monoclonal antibody therapy (mAb), which is delivered by intravenous infusion, as treatment options available for those at risk of serious illness from COVID-19.
.jpg)
